TNFRSF9 and rheumatoid arthritis: For instance, Treg cells in CBIA shared with the RA groups with features of increased expression of activation markers, including CD137 (TNFRSF9 or 4-1BB), CD134, and ICOS, while both groups shared features of decreased expression of immune-inhibitory markers.